Roche, Spark announce pending merger HSR deadline to be extended to May 24
MLex Summary: The end of the regulatory waiting period associated with Roche's pending acquisition of Spark Therapeutics will be extended until May 24, the companies announced in a release. Roche withdrew...To view the full article, register now.
Already a subscriber? Click here to view full article